Amflutizole

This classification denotes a xanthine oxidase inhibitor with the molecular formula C11H7F3N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 83N680M457, chemically known as 5-isothiazolecarboxylic acid, 4-amino-3-(3-(trifluoromethyl)phenyl)- but generally known as amflutizole, which bears US NIH Compound Identifier 54833. European Medicines Agency schedules Amflutizole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05420MIG. The term AMFLUTIZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). AMFLUTIZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amflutizole under HS 29341000 and SITC 51579. As of Q4 2014, AMFLUTIZOLE remains the US FDA Preferred Term for this commodity. Amflutizole bears US NLM identifiers UMLS ID C0051573 and NCI Concept Code C91009. SMILES: C1=CC(=CC(=C1)C(F)(F)F)C2=NSC(=C2N)C(=O)O.